Lv2
130 积分 2020-08-06 加入
Adjuvant Pertuzumab and Trastuzumab in Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in the APHINITY Trial: Third Interim Overall Survival Analysis With Efficacy Update
7天前
已完结
肿瘤研究中的实验动物福利问题探讨
21天前
已完结
Topoisomerase I inhibitors: Challenges, progress and the road ahead
2个月前
已完结
Theranostic Approach in Breast Cancer
4个月前
已完结
68Ga-Labeled Trastuzumab Fragments for ImmunoPET Imaging of Human Epidermal Growth Factor Receptor 2 Expression in Solid Cancers
4个月前
已完结
孕前和孕期保健指南
4个月前
已完结
[Guideline of preconception and prenatal care(2018)]
4个月前
已完结
Near-infrared photoimmunotherapy targeting Nectin-4 in a preclinical model of bladder cancer
8个月前
已完结
Small-molecule-mediated control of the anti-tumour activity and off-tumour toxicity of a supramolecular bispecific T cell engager
8个月前
已完结
中国NMPA、MARA和美国FDA、EPA以及OECD GLP规范的差异比对
1年前
已完结
皖公网安备34019202002308
